Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1147822

registered interest
date	02/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many referrals were made to Child and Adolescent Mental Health Services in England in each year from 2014-15 to 2018-19.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	293514
answer	answer is ministerial correction date of answer 07/10/2019 answer text <p>Information on the number of child and adolescent mental health referrals in England is available in the following table. This information was not collected prior to 2016/17.</p><table><tbody><tr><td><p>Year</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td><td><p>2018/19</p></td></tr><tr><td><p>England</p></td><td><p>204,022</p></td><td><p>281,429</p></td><td><p>396,841</p></td></tr></tbody></table><p>Source: Mental Health Services Dataset - NHS Digital</p><p> </p><p>Notes: A person may be referred more than once during any given year.</p><p>Annual figures are not directly comparable as the number of providers submitting data has increased year on year.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 07/10/2019 16:29:12 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	1604 label Biography information for Mr Virendra Sharma

1147823

registered interest
date	02/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the average waiting time was between (a) referral and first assessment and (b) referral and treatment for Child and Adolescent Mental Health Services in England in each year from 2014-15 to 2018-19.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	293515
answer	answer is ministerial correction date of answer 07/10/2019 answer text <p>The information requested is not held centrally.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 07/10/2019 16:34:41 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	1604 label Biography information for Mr Virendra Sharma

1142196

registered interest
date	25/07/2019
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Developing Countries: Abortion
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Development, what assessment he has made of the effect of the 2019 expansion of the US Government’s Protecting Life on Global Health Assistance policy on UK NGOs that also receive US Government health funding.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	282273
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>The UK government will continue to lead the world in our long-term support for comprehensive sexual and reproductive health and rights (SRHR), and to help women and girls get the information and services they need to give them control over their own lives and bodies. This is essential to achieving the Global Goals.</p><p> </p><p>Following the reintroduction and expansion of the Mexico City Policy in January 2017, we have kept in close contact with partners including UK NGOs to ensure the policy does not compromise UK-supported evidence-based comprehensive SRHR programming.</p><p> </p><p>The full implications of the further expansion of the Mexico City Policy in May 2019 are still emerging and we are closely monitoring developments. DFID is considering the implications, including with our partners, civil society and other donors.</p><p> </p><p>The UK will continue to defend SRHR through our programmes and our voice on the world stage.</p> answering member constituency South West Wiltshire answering member printed Dr Andrew Murrison grouped question UIN 282274 282275 question first answered 03/09/2019 16:20:46 answering member 1466 label Biography information for Dr Andrew Murrison
tabling member	1604 label Biography information for Mr Virendra Sharma

1142197

registered interest
date	25/07/2019
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Developing Countries: Abortion
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Development, what steps he is taking to ensure that UK NGOs are protected from the 2019 expansion of the US Government’s Protecting Life on Global Health Assistance policy.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	282274
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>The UK government will continue to lead the world in our long-term support for comprehensive sexual and reproductive health and rights (SRHR), and to help women and girls get the information and services they need to give them control over their own lives and bodies. This is essential to achieving the Global Goals.</p><p> </p><p>Following the reintroduction and expansion of the Mexico City Policy in January 2017, we have kept in close contact with partners including UK NGOs to ensure the policy does not compromise UK-supported evidence-based comprehensive SRHR programming.</p><p> </p><p>The full implications of the further expansion of the Mexico City Policy in May 2019 are still emerging and we are closely monitoring developments. DFID is considering the implications, including with our partners, civil society and other donors.</p><p> </p><p>The UK will continue to defend SRHR through our programmes and our voice on the world stage.</p> answering member constituency South West Wiltshire answering member printed Dr Andrew Murrison grouped question UIN 282273 282275 question first answered 03/09/2019 16:20:46 answering member 1466 label Biography information for Dr Andrew Murrison
tabling member	1604 label Biography information for Mr Virendra Sharma

1142198

registered interest
date	25/07/2019
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Developing Countries: Abortion
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Development, how he will ensure that funding allocated to NGOs is not used to enforce the US government’s anti-abortion policies under the expanded Protecting Life in Global Health Assistance rule.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	282275
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>The UK government will continue to lead the world in our long-term support for comprehensive sexual and reproductive health and rights (SRHR), and to help women and girls get the information and services they need to give them control over their own lives and bodies. This is essential to achieving the Global Goals.</p><p> </p><p>Following the reintroduction and expansion of the Mexico City Policy in January 2017, we have kept in close contact with partners including UK NGOs to ensure the policy does not compromise UK-supported evidence-based comprehensive SRHR programming.</p><p> </p><p>The full implications of the further expansion of the Mexico City Policy in May 2019 are still emerging and we are closely monitoring developments. DFID is considering the implications, including with our partners, civil society and other donors.</p><p> </p><p>The UK will continue to defend SRHR through our programmes and our voice on the world stage.</p> answering member constituency South West Wiltshire answering member printed Dr Andrew Murrison grouped question UIN 282273 282274 question first answered 03/09/2019 16:20:46 answering member 1466 label Biography information for Dr Andrew Murrison
tabling member	1604 label Biography information for Mr Virendra Sharma

1141269

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Ultrasonics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations his Department has received following recommendations from NICE on NHS England adopting a commissioning policy for MR-guided focused ultrasound for essential tremor; and if he will make a statement.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	280966
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>In June 2018, the National Institute for Heath and Care Excellence (NICE) developed interventional procedure guidance on ‘Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor’. NICE’s interventional procedures guidance looks at whether procedures are safe enough and work well enough for wider use in the National Health Service.</p><p>Due to limited evidence on efficacy, NICE’s guidance recommends that this procedure should not be used unless there are special arrangements for clinical governance, consent and audit or research.</p><p>A search of the Department’s Ministerial correspondence database from 1 January 2017 to 25 July 2019 has identified four items of correspondence received on the MR-guided focused ultrasound for essential tremor. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 03/09/2019 11:47:36 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1604 label Biography information for Mr Virendra Sharma

1141270

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Ultrasonics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment has been made by his Department's agencies and public bodies of the potential clinical benefits of MR-guided focused ultrasound as a treatment for essential tremor; and if he will make a statement.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	280967
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) has reviewed Magnetic Resonance Imaging-guided focused ultrasound (MRgFUS) as a treatment for essential tremor and published Interventional Procedure (IP) guidance on this treatment in June 2018. This concluded that the evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research.</p><p> </p><p>NHS England is in the early stages of developing a national clinical commissioning policy for MRgFUS for essential tremor. The policy will determine whether or not the intervention will or be routinely commissioned and include criteria to guide clinical decision-making about the patients who may be able to benefit.</p><p> </p><p>The development of a national clinical policy by NHS England is complex. This takes time, including proper consideration of the evidence and involvement of clinical experts. To ensure consistency and fairness, NHS England follows a standard three stage process. Full details can be found on the NHS England website at the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 280968 280969 280970 question first answered 03/09/2019 11:39:45 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1604 label Biography information for Mr Virendra Sharma

1141271

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Ultrasonics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment has been made by his Department's agencies and public bodies of the potential value for money of MR-guided focused ultrasound as a treatment for essential tremor; and if he will make a statement.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	280968
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) has reviewed Magnetic Resonance Imaging-guided focused ultrasound (MRgFUS) as a treatment for essential tremor and published Interventional Procedure (IP) guidance on this treatment in June 2018. This concluded that the evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research.</p><p> </p><p>NHS England is in the early stages of developing a national clinical commissioning policy for MRgFUS for essential tremor. The policy will determine whether or not the intervention will or be routinely commissioned and include criteria to guide clinical decision-making about the patients who may be able to benefit.</p><p> </p><p>The development of a national clinical policy by NHS England is complex. This takes time, including proper consideration of the evidence and involvement of clinical experts. To ensure consistency and fairness, NHS England follows a standard three stage process. Full details can be found on the NHS England website at the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 280967 280969 280970 question first answered 03/09/2019 11:39:45 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1604 label Biography information for Mr Virendra Sharma

1141272

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Ultrasonics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of people who would potentially benefit from MR-guided focused ultrasound as a treatment for essential tremor each year; and if he will make a statement.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	280969
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) has reviewed Magnetic Resonance Imaging-guided focused ultrasound (MRgFUS) as a treatment for essential tremor and published Interventional Procedure (IP) guidance on this treatment in June 2018. This concluded that the evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research.</p><p> </p><p>NHS England is in the early stages of developing a national clinical commissioning policy for MRgFUS for essential tremor. The policy will determine whether or not the intervention will or be routinely commissioned and include criteria to guide clinical decision-making about the patients who may be able to benefit.</p><p> </p><p>The development of a national clinical policy by NHS England is complex. This takes time, including proper consideration of the evidence and involvement of clinical experts. To ensure consistency and fairness, NHS England follows a standard three stage process. Full details can be found on the NHS England website at the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 280967 280968 280970 question first answered 03/09/2019 11:39:45 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1604 label Biography information for Mr Virendra Sharma

1141273

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Ultrasonics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if his Department will provide interim funding for NHS patients to access MR-guided focused ultrasound as a treatment for essential tremor at St Mary’s Hospital, Imperial College Healthcare Trust; and if he will make a statement.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	280970
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) has reviewed Magnetic Resonance Imaging-guided focused ultrasound (MRgFUS) as a treatment for essential tremor and published Interventional Procedure (IP) guidance on this treatment in June 2018. This concluded that the evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research.</p><p> </p><p>NHS England is in the early stages of developing a national clinical commissioning policy for MRgFUS for essential tremor. The policy will determine whether or not the intervention will or be routinely commissioned and include criteria to guide clinical decision-making about the patients who may be able to benefit.</p><p> </p><p>The development of a national clinical policy by NHS England is complex. This takes time, including proper consideration of the evidence and involvement of clinical experts. To ensure consistency and fairness, NHS England follows a standard three stage process. Full details can be found on the NHS England website at the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 280967 280968 280969 question first answered 03/09/2019 11:39:45 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1604 label Biography information for Mr Virendra Sharma